Drug Delivery
Volume 25, 2018 - Issue 1
Open access
2,134
Views
17
CrossRef citations to date
0
Altmetric
Research Article
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Chia-Yu SuSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROC; View further author information
, Michael ChenPh.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University, Taipei, Taiwan, ROC; View further author information
, Ling-Chun ChenDepartment of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu, Taiwan, ROC; View further author information
, Yuan-Soon HoGraduate Institute of Medical Sciences, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, ROC; View further author information
, Hsiu-O HoSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROC; View further author information
, Shyr-Yi LinDepartment of Primary Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan, ROC; ;Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC; ;TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan, ROC; View further author information
, Kuo-Hsiang ChuangPh.D. Program in Clinical Drug Development of Chinese Herbal Medicine, Taipei Medical University, Taipei, Taiwan, ROC; ;Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei, Taiwan, ROCCorrespondence[email protected]
View further author information
& View further author information
Ming-Thau SheuSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, ROC; Correspondence[email protected]
View further author information
show allView further author information
Pages 1066-1079
|
Received 24 Feb 2018, Accepted 16 Apr 2018, Published online: 02 May 2018
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.